In case you missed it, tech stocks are rallying again. After hitting an all-time high in December, the Nasdaq Composite index fell in January as DeepSeek upended the artificial intelligence (AI) universe with breakthroughs in training and inference efficiency.

If Recursion Pharmaceuticals can achieve its goal of cutting the time and money it takes to develop drugs by meaningful amounts, its stock could skyrocket over the long run. However, it isn't there yet,

Is the recent tech sell-off an opportunity or a warning? These leading AI stocks look enticing at today's lower share prices.